yosua butar butar, YB and Puspa Wardhani, Puspa (2022) Thalassemia β Major in Confirmed Covid-19 Patient: A Case Report. Pharmacognosy Journal, 14 (4). ISSN 445-449

Text yosua butar butar.pdf Download (592kB)

Abstract

The incidence of Thalassemia with confirmed Covid 19 is very rare. The aim of this study is to know the prognosis and evaluate the management of therapy in thalassemia β Mayor patients with COVID-19. This case study describes the progression of Thalassemia β Mayor with COVID 19 starting from how to establish the diagnosis of Thalassemia β Mayor and COVID 19 until how to treat thalassemia β Mayor patients with COVID-19 This case study result describes that COVID 19 aggravates thalassemia β Mayor. Infection can adversely affect thalassemia. Giving Blood transfusions must be done due to anemia in Thalassemia, but it will have an impact on the accumulation of iron in the body which will increase the severity of the infection. The administration of iron-chelation drugs is beneficial for Covid but on the other hand, it is contraindicated in Thalassemia patients

Item Type:	Article
Subjects:	R Medicine > RC Internal medicine > RC31-1245 Internal medicine
Divisions:	01. Fakultas Kedokteran > Patologi Klinik
Creators:	Creators NIM yosua butar butar, YB UNSPECIFIED Puspa Wardhani, Puspa NIDN0025027506
Contributors:	Contribution Name NIDN / NIDK Author UNSPECIFIED UNSPECIFIED Author UNSPECIFIED UNSPECIFIED
Depositing User:	Nona Henggar Anindiarti
Date Deposited:	27 May 2024 00:23
Last Modified:	27 May 2024 00:23
URI:	http://repository.unair.ac.id/id/eprint/133192
Sosial Share:

Actions (login required)

View Item